To investigate whether TGH deficiency would attenuate progression to the inflammatory steatohepatitis, we used two different NASH mouse models: Pemt−/− mice fed HFD for 10 weeks and Ldlr−/− mice fed WTD for 12 weeks. This evidence concerns the gene CES1 and metabolic dysfunction-associated steatohepatitis.